Cargando…

Anti-Saccharomyces cerevisiae Antibody in Pediatric Crohn’s Disease Patients without Mucosal Healing Is a Useful Marker of Mucosal Damage

BACKGROUND/AIMS: We evaluated whether anti-Saccharomyces cerevisiae antibody (ASCA) titers are associated with diagnostic findings, disease activity, Paris classification phenotypes, and persistence after infliximab (IFX) treatment in children with Crohn’s disease (CD). We also investigated the role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Mi Jin, Kim, Eunsil, Kang, Ben, Lee, Yoon, Kang, Eun-Suk, Choe, Yon Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444098/ https://www.ncbi.nlm.nih.gov/pubmed/33376230 http://dx.doi.org/10.5009/gnl20212

Ejemplares similares

Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease Patients
por: Choi, So Yoon, et al.
Publicado: (2020)

Association between Fecal Calprotectin and Mucosal Healing in Pediatric Patients with Crohn’s Disease Who Have Achieved Sustained Clinical Remission with Anti-Tumor Necrosis Factor Agents
por: Lee, Yoo Min, et al.
Publicado: (2022)

Mucosal Healing Is Associated With the Reduced Disabling Disease in Crohn's Disease
por: Huang, Shanshan, et al.
Publicado: (2019)

Change in the treatment strategy for pediatric Crohn's disease
por: Kim, Mi Jin, et al.
Publicado: (2010)

Targeting mucosal healing in Crohn’s disease: what the clinician needs to know
por: Klenske, Entcho, et al.
Publicado: (2019)

MR Enterography Scores Correlate with Degree of Mucosal Healing in Pediatric Crohn’s Disease: A Pilot Study
por: Gladkikh, Maria, et al.
Publicado: (2023)

Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn’s Disease: A Pilot Study
por: Kim, Yoon-Zi, et al.
Publicado: (2023)

Comparison of transmural healing and mucosal healing as predictors of positive long-term outcomes in Crohn’s disease
por: Ma, Li, et al.
Publicado: (2021)

Utility of Computed Tomographic Enteroclysis/Enterography for the Assessment of Mucosal Healing in Crohn's Disease
por: Hashimoto, Shinichi, et al.
Publicado: (2013)

Multiple drugs: Saccharomyces cerevisiae infection, oral mucosal lesions and geographical tongue: case report
Publicado: (2020)

Characterization of the Mucosally-Adherent Duodenal Microbiome in Children with and without Crohn’s Disease
por: Schmidt, Kenneth, et al.
Publicado: (2022)

A Computational Platform Integrating a Mechanistic Model of Crohn’s Disease for Predicting Temporal Progression of Mucosal Damage and Healing
por: Venkatapurapu, Sai Phanindra, et al.
Publicado: (2022)

Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn’s disease
por: Choi, So Yoon, et al.
Publicado: (2023)

Oral exclusive enteral nutrition induces mucosal and transmural healing in patients with Crohn’s disease
por: Chen, Jia-Min, et al.
Publicado: (2019)

Adalimumab for endoscopic and histopathological mucosal healing in paediatric patients with moderate to severe Crohn’s disease
por: Szymanska, Edyta, et al.
Publicado: (2016)

Can serum histone H4 levels predict mucosal healing in Crohn’s disease?
por: Köker, Ibrahim Hakki, et al.
Publicado: (2021)

Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn’s Disease
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Correction to: A Computational Platform Integrating a Mechanistic Model of Crohn’s Disease for Predicting Temporal Progression of Mucosal Damage and Healing
por: Venkatapurapu, Sai Phanindra, et al.
Publicado: (2022)

Factors associated with the achievement of mucosal healing in Crohn’s disease: the benefit of endoscopic monitoring in treating to target
por: Mao, Ren, et al.
Publicado: (2017)

Efficacy of infliximab treatment on the mucosal healing of different intestinal segments in patients with ileocolonic Crohn’s disease
por: Wu, Yaling, et al.
Publicado: (2020)

Mucosal healing of small intestinal stricture is associated with improved prognosis post-dilation in Crohn’s disease
por: Hibiya, Shuji, et al.
Publicado: (2022)

Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
por: Dorofeyev, A. E., et al.
Publicado: (2013)

Fecal Calprotectin Assay at an Early Stage of Treatment Can Be Used as a Surrogate Marker to Predict Clinical Remission and Mucosal Healing in Pediatric Crohn’s Disease
por: Lee, Yeoun Joo, et al.
Publicado: (2022)

Infliximab Therapy for Children with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down Strategy
por: Kim, Mi Jin, et al.
Publicado: (2021)

Induction of Remission in Pediatric Crohn’s Disease Patients Assessed by the Mucosal Inflammation Noninvasive Index
por: Herman, Roma, et al.
Publicado: (2021)

Mucosal microbiome is predictive of pediatric Crohn’s disease across geographic regions in North America
por: Shah, Rajesh, et al.
Publicado: (2023)

Differences in Immunophenotyping of Mucosal Lymphocytes Between Ulcerative Colitis and Crohn’s Disease
por: Lee, Heung Bum, et al.
Publicado: (1997)

Different healing process of esophageal large mucosal defects by endoscopic mucosal dissection between with and without steroid injection in an animal model
por: Nonaka, Kouichi, et al.
Publicado: (2013)

Intramural Recurrence Without Mucosal Lesions After an Endoscopic Mucosal Resection for Early Colorectal Cancer
por: Kim, Min Sung, et al.
Publicado: (2013)

Low-dose azathioprine effectively improves mucosal healing in Chinese patients with small bowel Crohn's disease
por: Yu, Li Fen, et al.
Publicado: (2014)

Thalidomide induces mucosal healing in postoperative Crohn disease endoscopic recurrence: Case report and literature review
por: Hu, Huiqin, et al.
Publicado: (2016)

Trough level of infliximab is useful for assessing mucosal healing in Crohn's disease: a prospective cohort study
por: Koga, Akihiro, et al.
Publicado: (2018)

Predicting Mucosal Healing in Crohn’s Disease: A Nomogram Model Developed from a Retrospective Cohort
por: Tang, Nana, et al.
Publicado: (2022)

Early Biologic Treatment in Pediatric Crohn's Disease: Catching the Therapeutic Window of Opportunity in Early Disease by Treat-to-Target
por: Kang, Ben, et al.
Publicado: (2018)

The SES-CD Could Be a Predictor of Short- and Long-Term Mucosal Healing After Exclusive Enteral Nutrition in Pediatric Crohn’s Disease Patients
por: Tang, Wenjuan, et al.
Publicado: (2022)

Adalimumab Treatment in Pediatric-Onset Crohn's Disease Patients after Infliximab Failure: A Single Center Study
por: Song, Won Jae, et al.
Publicado: (2016)

Differences in Features and Course of Mucosal Type Eosinophilic Gastroenteritis between Korean Infants and Children
por: Choi, Bong Seok, et al.
Publicado: (2015)

Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission
por: Lin, Xiaoqin, et al.
Publicado: (2020)

Combination of serological biomarkers and clinical features to predict mucosal healing in Crohn’s disease: a multicenter cohort study
por: Tang, Nana, et al.
Publicado: (2022)

Efficacy of Early Infliximab Treatment for Pediatric Crohn's Disease: A Three-year Follow-up
por: Lee, Yun Seok, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0v5c9j2d0ef1o8gnm04iadm347